¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cellulose Sodium Phosphate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • triortho cresyl phosphate poisoning
    Æ®¸®¿À¸£¼ÒÅ©·¹½ÇÆ÷½ºÆäÀÌÆ®Áßµ¶(ÊÙÌ¡ ËÄ).
  • triose phosphate isomerase deficiency
    »ïź´çÀλêÀ̼Ҹ޶ó¾ÆÁ¦°áÇÌÁõ(ß²÷© ÓØìÝß«¡­ÌÀù¹ñø).
  • triose phosphate isomerase deficiency
    »ïź´çÀλêÀ̼Ҹ޶ó¾ÆÁ¦°áÇÌÁõ(ß²÷© ÓØìÝß«¡­ÌÀù¹ñø)
  • triple phosphate
    »ïÁßÀλ꿰(ß²ñììÝß«æú).
  • triple phosphate crystal
    »ïÁßÀλ꿰°áÁ¤
  • trisodium phosphate
    »ï³ªÆ®·ýÀλ꿰
  • zephiran-trisodium phosphate
    Á¦ÇǶõ-Æ®¸®¼Òµð¿ò Àλ꿰
  • zinc phosphate
    Á¦»ïÀλê(ð¯ß²ìÝß«)¾Æ¿¬.
  • zinc phosphate cement
    ÀÎ»ê¾Æ¿¬½Ã¸àÆ®.
  • calcium sodium exchange
    Ä®½·-³ªÆ®·ý ±³È¯(-Îßüµ)
  • exchangeable sodium
    ±³È¯¼º ³ªÆ®·ý
  • exsiccated sodium arsenate<³ª> sodii ar se nas exsiccatus
    °ÇÁ¶ºñ»ê³ªÆ® ·ý.
  • fluorescein sodium
    Ç÷οÀ·¹½Å ³ªÆ®·ý.
  • fractional sodium excretion
    ºÐȹ¼º³ªÆ®·ý¹è¼³
  • hexobarbital sodium
    Çí»ç¹Ù¸£ºñÅ»³ªÆ®·ý.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • reductive pentose phosphate cycle
    ȯ¿ø¼º(ü½êªàõ) Àλê(×òß«)ÆæÅ佺 ȸ·Î(üÞÖØ)
  • riboflavin phosphate
    ÀÎ»ê ¶óÀ̺¸Çöóºó
  • riboflavin-5'-phosphate
    5` ÀÎ»ê ¶óÀ̺¸Çöóºó
  • undecaprenol phosphate
    ¾ðµ¥Ä«ÇÁ·¹³î Àλê(×òß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CN caudate nucleus; cellulose nitrate; charge nurse; child nutrition; chloroacetophenone; clinical nurs...
DEAE diethylaminoethyl [cellulose]
HE half-scan with extrapolation; hard exudate; hektoen enteric [agar]; hemagglutinating encephalomyelit...
HEC hamster embryo cell; Health Education Council; human endothelial cell; hydroxyergocalciferol; hydrox...
MC mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CAB cellulose acetate buterate
DSC dextran sulfate cellulose
RC regenerated cellulose
P(i) phosphate and inorganic phosphate
Pi 6-phosphate , inorganic phosphate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sodium monofluorophosphate
    ÀÏ ºÒ¼Ò ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=
  • sodium nitrate
    ¾ÆÁú»ê ³ªÆ®·ý
    ¹é»öÀ̳ª ¾à°£ ³ë¶õ»öÀÇ °ú¸³¼º ºÐ¸», ¹é»öÀÇ ºÒÅõ¸íÇÑ ¿ëÀ¶ µ¢¾î¸® ¶Ç´Â ¸·´ë ¸ð¾ç. û»ê Ä®¸® Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦·Î »ç¿ëÇÑ´Ù. Çù½ÉÁõ, õ½ÄÀÇ °æ¿ì¿¡µµ »ç¿ëµÇ¸ç, º¹Åë, °æ·Ã¼º ´ëÀå¿°°ú °°Àº »óÅ¿¡µµ ÀÌ¿ëµÇ°í ÀÖ´Ù.
  • sodium perborate
    °úºØ»ê ³ªÆ®·ý
    ºØ»êÀ̳ª ºØ»ê³ªÆ®·ýÀÌ ³ªÆ®·ý ¶Ç´Â °ú»êÈ­ ¼ö¼Ò¿Í »óÈ£ÀÛ¿ëÇÏ¿© »ý¼ºµÈ È­ÇÕ¹°, ¹æºÎÁ¦. 2% ¿ë¾×À¸·Î´Â ¾çÄ¡Áú ¾×À¸·Îµµ »ç¿ëµÈ´Ù.
  • sodium polystyrene sulfonate
    Æú¸®½ºÅ¸À̸° ¼³Æù ³ªÆ®·ý
    ³ªÆ®·ý ÇüÅÂÀÇ ¾çÀ̿ ±³È¯ ¼öÁö 1g´ç ¹«¼ö±âÀÇ Ä®·ý 110-135mg °ú ±³È¯. °úÄ®·ý Ç÷Áß Ä¡·á¿¡ »ç¿ëÇÑ´Ù.
  • sodium pump
    ³ªÆ®·ý ÆßÇÁ
  • sodium salicylate
    »ì¸®½Ç»ê ³ªÆ®·ý
    ¹«Á¤ÇüÀÇ °áÁ¤¼º ºÐ¸» ¶Ç´Â Àμ³·Î¼­ Á¸ÀçÇÑ´Ù. ÁøÅëÁ¦, ÇØ¿­Á¦, Ç×°üÀý¿°Á¦·Î »ç¿ëµÇ¸ç °æ±¸ÀûÀ¸·Î Åõ¿©µÈ´Ù.
  • sodium sulfate
    Ȳ»ê ³ªÆ®·ý
    ¹Ù·ý Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦ ¼³»ç ¾àÀ¸·Î »ç¿ëÇϸç, °¨¿°µÈ »óó¿¡ ´ëÇÑ ÃÖ¸²ÇÁ ¾àÀ¸·Î¼­ ±¹¼ÒÀûÀ¸·Î »ç¿ëÇϱ⵵ ÇÑ´Ù.
  • sodium tetradecyl sulfate
    Åׯ®¶óµ¥½ÇȲ»ê³ªÆ®·ý
    °æÈ­¼ºÀ» °®´Â À½À̿ °è¸éȰ¼ºÁ¦, ¹é»öÀÇ ¹Ð¶ø¼º °íü. ½ÀÀ±Á¦·Î¼­ ¾²À̸ç, Á¤¸Æ·ù¿Í Ä¡ÁúÀÇ Ä¡·á·Îµµ »ç¿ëÇÑ´Ù.
  • sodium transport system
    ³ªÆ®·ý ¿î¹Ý°è
  • sodium-potassium exchange resin
    ¼Òµð¿ò-Æ÷Ÿ½· ±³È¯ ¼öÁö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
beta-(2-furyl)-acryloyl phosphate hydrolase <enzyme> Used as synthetic substrate for atpase assay
Registry number: EC 3.6.1.-
Synonym: bfa phosphatase
(26 Jun 1999)
bis(monoacylglycero)phosphate synthetase <enzyme> Converts phosphatidylglycerol, 1-acyl- or 2-acyllysophosphatidylglycerol to bis(monoacylglycero)phosphate
Registry number: EC 2.3.1.-
(26 Jun 1999)
bone phosphate Ca3(PO4)2;used as an antacid.
Synonym: bone ash, bone phosphate, tertiary calcium phosphate, tricalcium phosphate, whitlockite.
(05 Mar 2000)
calcium monohydrogen phosphate CaHPO4-2H2O;used as a calcium and phosphorus dietary supplement.
Synonym: calcium monohydrogen phosphate, secondary calcium phosphate.
(05 Mar 2000)
carbamoyl phosphate H2NCO-OPO32-;a reactive intermediate capable of transferring its carbamoyl group (H2NCO-) to an acceptor molecule, forming citrulline from ornithine in the urea cycle, and ureidosuccinic acid from aspartic acid in pyrimidine ring formation.
(05 Mar 2000)
carbamoyl-phosphate synthase (ammonia) <enzyme> An enzyme that catalyses the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. This enzyme is specific for arginine biosynthesis or the urea cycle.
Chemical name: Carbon dioxide:ammonia ligase (ADP-forming, carbamate-phosphorylating)
Registry number: EC 6.3.4.16
(12 Dec 1998)
carbamoyl-phosphate synthase (glutamine-hydrolyzing) <enzyme> An enzyme that catalyses the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. This enzyme is important in the de novo biosynthesis of pyrimidines.
Chemical name: Carbon dioxide:L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating)
Registry number: EC 6.3.5.5
(12 Dec 1998)
carbamoyl phosphate synthetase A phosphotransferase catalyzing the formation of carbamoyl phosphate. There are two significant isozymes. Carbomoyl phosphate synthetase I is a mitochondrial enzyme that catalyses the reaction of 2ATP, NH3, CO2, and H2O to carbamoyl phosphate, 2ADP, and Pi. It is activated by N-acetylglutamate and participates in urea biosynthesis.
A deficiency of carbamoyl phosphate synthetase I can result in hyperammonaemia. Carbamoyl phosphate synthetase II is a cytosolic enzyme that, under physiological conditions, uses l-glutamine as the nitrogen source (producing l-glutamate) instead of NH3, is not activated by N-acetylglutamate, and is found in pyrimidine biosynthesis.
(05 Mar 2000)
carbamyl phosphate <chemical> Phosphate salt of carbamic acid.
Chemical name: Carbamic acid, monoanhydride with phosphoric acid
(12 Dec 1998)
galactose-1-phosphate A phosphorylated derivative of galactose that is key in galactose metabolism; accumulates in certain types of galactosaemia.
(05 Mar 2000)
galactose-1-phosphate uridylyltransferase <enzyme> An enzyme catalyzing the reaction of UTP and alpha-d-galactose 1-phosphate to form UDPgalactose and pyrophosphate, the second and most important step in the metabolism of d-galactose; a deficiency of this enzyme results in an accumulation of galactose, galactose-1-phosphate, and galactitol.
(05 Mar 2000)
galactose-6-phosphate dehydrogenase <enzyme> Possibly a ketoaldose, phosphorylated at primary alcoholic group; found in goat liver cytoplasm, requires nad, has high substrate specificity
Registry number: EC 1.1.1.-
Synonym: hexose-6-phosphate dehydrogenase
(26 Jun 1999)
galactose-6-phosphate isomerase <enzyme> Converts galactose 6-phosphate to tagatose 6-phosphate
Registry number: EC 5.3.1.-
Synonym: galactose 6-phosphate isomerase, gal-6-p isomerase, tagatose-6-phosphate isomerase
(26 Jun 1999)
pantetheine 4'-phosphate The prosthetic group of the acyl carrier protein in the fatty acid synthase complex.
Synonym: pantetheine 4'-phosphate.
(05 Mar 2000)
mannose-1-phosphate guanylyltransferase <enzyme> A transferase that catalyses the transfer of GDP to the mannose of mannose-1-phosphate.
Consider also the bifunctional enzyme, phosphomannose isomerase-guanosine diphospho-d-mannose pyrophosphorylase; rfbm has similarity to long-chain, iron-containing alcohol dehydrogenases
Registry number: EC 2.7.7.13
Synonym: GDPmannose phosphorylase, GDP mannose pyrophosphorylase, GTP-alpha-d-mannose-1-phosphate guanylyltransferase, GDP-mannose pyrophosphorylase, rfbm gene product, rfbm protein
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á